Safety and Effectiveness of NXY-059 for the Treatment of Patients who have Suffered from a Stroke

Exclusion Criteria

• - Unconsciousness
• - Subjects who are unlikely to complete the infusion of investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
• - Severe illness with life expectancy less than 6 months.
• - Known severe kidney disorder.
• - Current known alcohol or illicit drug abuse or dependence.
• - Pregnant or breast-feeding.
• - Treatment with acetazolamide and methotrexate is not permitted during the infusion
• - Participation in a previous clinical study within 30 days.
• - Meets all other exclusion criteria.